Learn the Facts. Know the Evidence. Become an Advocate.
May 16, 2022
May 26, 2022
In mathematical modeling study, investigators find benefits outweigh risks of biennial mammograms for high-risk women in their 40s A study
May 25, 2022
NBCC made the case in 2008 that accelerated approval for bevacizumab (Avastin®) was lowering the bar on drug approval. There
Save my name, email, and website in this browser for the next time I comment.